Charles Schwab’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $129M | Buy |
1,213,963
+144,573
| +14% | +$17.5M | 0.02% | 642 |
|
|
2026
Q1 | $175M | Buy |
1,069,390
+42,035
| +4% | +$6.46M | 0.03% | 470 |
|
|
2025
Q4 | $179M | Buy |
1,027,355
+52,076
| +5% | +$9.5M | 0.03% | 440 |
|
|
2025
Q3 | $140M | Sell |
975,279
-324,289
| -25% | -$39.7M | 0.02% | 541 |
|
|
2025
Q2 | $131M | Sell |
1,299,568
-303,087
| -19% | -$23.2M | 0.02% | 558 |
|
|
2025
Q1 | $122M | Buy |
1,602,655
+56,048
| +4% | +$4.29M | 0.02% | 560 |
|
|
2024
Q4 | $107M | Buy |
1,546,607
+102,341
| +7% | +$7.37M | 0.02% | 627 |
|
|
2024
Q3 | $105M | Buy |
1,444,266
+137,670
| +11% | +$10.2M | 0.02% | 626 |
|
|
2024
Q2 | $87.5M | Buy |
1,306,596
+179,829
| +16% | +$6.97M | 0.02% | 706 |
|
|
2024
Q1 | $30.6M | Sell |
1,126,767
-1,669
| -0.1% | -$46.7K | 0.01% | 1351 |
|
|
2023
Q4 | $35M | Buy |
1,128,436
+28,629
| +3% | +$742K | 0.01% | 1235 |
|
|
2023
Q3 | $27.8M | Buy |
1,099,807
+88,589
| +9% | +$2.03M | 0.01% | 1284 |
|
|
2023
Q2 | $21.3M | Buy |
1,011,218
+5,152
| +0.5% | +$97.8K | 0.01% | 1457 |
|
|
2023
Q1 | $17.2M | Sell |
1,006,066
-391
| -0% | -$7.6K | 0.01% | 1582 |
|
|
2022
Q4 | $20.1M | Buy |
1,006,457
+136,230
| +16% | +$2.63M | 0.01% | 1439 |
|
|
2022
Q3 | $18.7M | Buy |
870,227
+19,566
| +2% | +$469K | 0.01% | 1421 |
|
|
2022
Q2 | $16.8M | Sell |
850,661
-9,052
| -1% | -$190K | 0.01% | 1530 |
|
|
2022
Q1 | $20.2M | Buy |
859,713
+10,139
| +1% | +$236K | 0.01% | 1544 |
|
|
2021
Q4 | $23.1M | Buy |
849,574
+20,621
| +2% | +$590K | 0.01% | 1466 |
|
|
2021
Q3 | $22.8M | Buy |
828,953
+32,155
| +4% | +$844K | 0.01% | 1473 |
|
|
2021
Q2 | $22.7M | Buy |
796,798
+64,281
| +9% | +$1.91M | 0.01% | 1488 |
|
|
2021
Q1 | $24.9M | Sell |
732,517
-10,999
| -1% | -$420K | 0.01% | 1355 |
|
|
2020
Q4 | $24.8M | Buy |
743,516
+44,952
| +6% | +$1.64M | 0.01% | 1238 |
|
|
2020
Q3 | $22.5M | Buy |
698,564
+26,977
| +4% | +$775K | 0.01% | 1129 |
|
|
2020
Q2 | $18.5M | Buy |
671,587
+114,371
| +21% | +$2.71M | 0.01% | 1240 |
|
|
2020
Q1 | $8.93M | Buy |
557,216
+10,622
| +2% | +$252K | 0.01% | 1508 |
|
|
2019
Q4 | $13.1M | Buy |
546,594
+11,348
| +2% | +$231K | 0.01% | 1505 |
|
|
2019
Q3 | $9.44M | Buy |
535,246
+45,174
| +9% | +$872K | 0.01% | 1629 |
|
|
2019
Q2 | $12.5M | Buy |
490,072
+47,353
| +11% | +$1.32M | 0.01% | 1447 |
|
|
2019
Q1 | $12.9M | Buy |
442,719
+23,386
| +6% | +$606K | 0.01% | 1427 |
|
|
2018
Q4 | $5.5M | Buy |
419,333
+1,594
| +0.4% | +$25.4K | ﹤0.01% | 1862 |
|
|
2018
Q3 | $8.45M | Buy |
417,739
+17,609
| +4% | +$398K | 0.01% | 1746 |
|
|
2018
Q2 | $9.46M | Buy |
400,130
+18,686
| +5% | +$481K | 0.01% | 1639 |
|
|
2018
Q1 | $8.59M | Buy |
381,444
+19,782
| +5% | +$521K | 0.01% | 1606 |
|
|
2017
Q4 | $11.3M | Buy |
361,662
+13,864
| +4% | +$410K | 0.01% | 1387 |
|
|
2017
Q3 | $10.9M | Buy |
347,798
+66,148
| +23% | +$1.26M | 0.01% | 1363 |
|
|
2017
Q2 | $4.83M | Sell |
281,650
-1,517
| -0.5% | -$25.9K | ﹤0.01% | 1835 |
|
|
2017
Q1 | $4.96M | Buy |
283,167
+18,331
| +7% | +$283K | 0.01% | 1759 |
|
|
2016
Q4 | $3.5M | Buy |
264,836
+14,670
| +6% | +$200K | ﹤0.01% | 1928 |
|
|
2016
Q3 | $3.63M | Buy |
250,166
+12,342
| +5% | +$154K | ﹤0.01% | 1837 |
|
|
2016
Q2 | $2.35M | Buy |
237,824
+17,360
| +8% | +$203K | ﹤0.01% | 1993 |
|
|
2016
Q1 | $2.79M | Buy |
220,464
+4,833
| +2% | +$63.5K | ﹤0.01% | 1878 |
|
|
2015
Q4 | $3.91M | Buy |
215,631
+33,743
| +19% | +$594K | 0.01% | 1684 |
|
|
2015
Q3 | $3.38M | Buy |
181,888
+74,574
| +69% | +$1.86M | 0.01% | 1741 |
|
|
2015
Q2 | $2.62M | Buy |
107,314
+37,514
| +54% | +$852K | ﹤0.01% | 1944 |
|
|
2015
Q1 | $1.45M | Hold |
69,800
| – | – | ﹤0.01% | 2229 |
|
|
2014
Q4 | $1.08M | Sell |
69,800
-8,800
| -11% | -$125K | ﹤0.01% | 2314 |
|
|
2014
Q3 | $1.03M | Buy |
78,600
+21,000
| +36% | +$317K | ﹤0.01% | 2289 |
|
|
2014
Q2 | $1.15M | Buy |
57,600
+8,300
| +17% | +$123K | ﹤0.01% | 2253 |
|
|
2014
Q1 | $939K | Hold |
49,300
| – | – | ﹤0.01% | 2319 |
|
|
2013
Q4 | $839K | Hold |
49,300
| – | – | ﹤0.01% | 2355 |
|
|
2013
Q3 | $788K | Buy |
49,300
+9,000
| +22% | +$114K | ﹤0.01% | 2334 |
|
|
2013
Q2 | $392K | Buy |
+40,300
| New | +$412K | ﹤0.01% | 2622 |
|
Other funds holding INSM
BBA
DGM
OAG
Charles Schwab's INSM Position: Q2 2026 in Review
Charles Schwab increased its Insmed (INSM) stake by 14% in Q2 2026, buying an estimated $17.5M and bringing the position to 1,213,963 shares worth $129M. The position accounts for 0.02% of the portfolio, ranked #642.
Charles Schwab first reported a position in INSM in Q2 2013 and has held it in 53 quarters since. The position peaked at $179M in Q4 2025. 664 funds tracked by Wall St. Rank hold INSM as of Q2 2026.
- Charles Schwab held 1,213,963 shares of Insmed worth $129M as of Q2 2026.
- Charles Schwab bought 144,573 Insmed shares in Q2 2026, an estimated $17.5M.
- Insmed made up 0.02% of Charles Schwab's portfolio in Q2 2026, its #642 holding.
- Charles Schwab first reported a position in Insmed in Q2 2013 and has held it in 53 quarters since.
- Charles Schwab's Insmed position peaked at $179M in Q4 2025.
- 664 funds tracked by Wall St. Rank held Insmed as of Q2 2026.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.